The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator
Open accessAbstract
Macular edema is a major cause of vision loss in patients with central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO). It is not clear how much of the edema is due to hydrodynamic changes from the obstruction and how much is due to chemical mediators. Patients with macular edema due to CRVO (n = 20) or BRVO (n = 20) were randomized to receive three monthly injections of 0.3 or 0.5 mg of ranibizumab. At the primary endpoint, month 3, the median improvement in letters read at 4 m was 17 in the 0.3-mg group and 14 in the 0.5-mg group for CRVO, and 10 and 18, respectively for the BRVO group. Optical coherence tomography (OCT) showed that compared to injections of 0.3 mg, injections of 0.5 mg of ranibizumab tended to cause more rapid reductions of central retinal thickening that lasted longer between injections, but in 3 months, excess central retinal thickening which is a quantitative assessment of the macular edema, was reduced by approximately 90% in all four treatment groups. There was no correlation between the amount of improvement and duration of disease or patient age at baseline, but there was some correlation between the aqueous vascular endothelial growth factor (VEGF) level at baseline and amount of improvement. These data indicate that excess production of VEGF in the retinas of patients with CRVO or BRVO is a major contributor to macular edema and suggest that additional studies investigating the efficacy of intraocular injections of ranibizumab are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huang, D., Swanson, E. A., Lin, C. P., Schuman, J. S., Stinson, W. G., Chang, W., Hee, M. R., Flotte, T., Gregory, K., Puliafito, C. A., et al. (1991) · Science · doi:10.1126/science.1957169 · Cited by 13,788
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Optical Coherence Tomography of the Human Retina
Hee, M. R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100030081025 · Cited by 1,634
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Natural History and Clinical Management of Central Retinal Vein Occlusion
(1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150488006 · Cited by 663
Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion
Clarkson, J. G., Chuang, E., Gass, D., Pedroso, M., Cubillas, T., Duria, E. S., Hess, D. J., Rams, I., Ball, M., Gutierrez, A., et al. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30849-4 · Cited by 508
Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion
Finkelstein, D. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33651-0 · Cited by 466
ITURRALDE, D., SPAIDE, R. F., MEYERLE, C. B., KLANCNIK, J. M., YANNUZZI, L. A., FISHER, Y. L., SORENSON, J., SLAKTER, J. S., FREUND, K. B., COONEY, M., et al. (2006) · Retina · doi:10.1097/00006982-200603000-00005 · Cited by 460
Normal Macular Thickness Measurements in Healthy Eyes Using Stratus Optical Coherence Tomography
Chan, A. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.2.193 · Cited by 424
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.
Green, W. R., Chan, C. –., Hutchins, G. M., & Terry, J. M. (1981) · PubMed · Cited by 401
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050110038020 · Cited by 287
OZAKI, H., HAYASHI, H., VINORES, S. A., MOROMIZATO, Y., CAMPOCHIARO, P. A., & OSHIMA, K. (1997) · Experimental Eye Research · doi:10.1006/exer.1996.0239 · Cited by 260
Self-citationRisk Factors for Branch Retinal Vein Occlusion
The Eye Disease Case-control Study Group (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71345-5 · Cited by 249
RABENA, M. D., PIERAMICI, D. J., CASTELLARIN, A. A., NASIR, M. A., & AVERY, R. L. (2007) · Retina · doi:10.1097/iae.0b013e318030e77e · Cited by 245
Arteriovenous Crossing Patterns in Branch Retinal Vein Occlusion
Zhao, J., Sastry, S. M., Sperduto, R. D., Chew, E. Y., Remaley, N. A., Yannuzzi, L. A., Sorenson, J. A., Seddon, J. M., Gragoudas, E. S., Puliafito, C. A., et al. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31633-7 · Cited by 207
Self-citationInterventions for Central Retinal Vein Occlusion
Mohamed, Q., McIntosh, R. L., Saw, S. M., & Wong, T. Y. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.11.011 · Cited by 206
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS: IBeVO Study
COSTA, R. A., JORGE, R., CALUCCI, D., MELO, L. A., CARDILLO, J. A., & SCOTT, I. U. (2007) · Retina · doi:10.1097/iae.0b013e31802eff83 · Cited by 180
Pai, S. A., Shetty, R., Vijayan, P. B., Venkatasubramaniam, G., Yadav, N. K., Shetty, B. K., Babu, R. B., & Narayana, K. M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.037 · Cited by 177
Anatomy of Arteriovenous Crossings in Branch Retinal Vein Occlusion
Weinberg, D., Dodwell, D. G., & Fern, S. A. (1990) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74554-4 · Cited by 158
Bevacizumab in retinal vein occlusion-results of a prospective case series
Stahl, A., Agostini, H. T., Hansen, L. L., & Feltgen, N. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0569-6 · Cited by 121
Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik, N. L., Vinores, S. A., Xiao, W., Mori, K., Turon, T., Hudish, T. M., Dong, S., & Campochiaro, P. A. (2002) · PubMed · Cited by 112
Self-citationRodriguez, C. R., Fei, D. T., Keyt, B. A., & Baly, D. L. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00131-8 · Cited by 33
Cited by
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Self-citationHaller, J. A., Bandello, F., Belfort, R., Blumenkranz, M. S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y.-H., Jacques, M.-L., Jiao, J., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.032 · Cited by 1,068
Self-citationRanibizumab for Macular Edema following Branch Retinal Vein Occlusion
Campochiaro, P. A., Heier, J. S., Feiner, L., Gray, S., Saroj, N., Rundle, A. C., Murahashi, W. Y., & Rubio, R. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.021 · Cited by 818
Self-citationCampochiaro, P. A., Brown, D. M., Awh, C. C., Lee, S. Y., Gray, S., Saroj, N., Murahashi, W. Y., & Rubio, R. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.038 · Cited by 711
Self-citationMolecular pathogenesis of retinal and choroidal vascular diseases
Campochiaro, P. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.002 · Cited by 545
Self-citation
Metadata
- Authors
- Campochiaro, P. A., Hafiz, G., Shah, S. M., Nguyen, Q. D., Ying, H., Do, D. V., Quinlan, E., Zimmer-Galler, I., Haller, J. A., Solomon, S. D., Sung, J. U., Hadi, Y., Janjua, K. A., Jawed, N., Choy, D. F., & Arron, J. R.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 16
- Issue
- 4
- Pages
- 791-799
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1977995451
- Cited by
- 321
- References
- 23
- FWCI
- 28.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.